Skip to Content
MilliporeSigma
  • Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.

Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.

The Kaohsiung journal of medical sciences (2011-04-06)
Yueh-Hung Chou, Hsin-Yi Wang, Min-Shu Hsieh
ABSTRACT

Kayexalate (sodium polystyrene sulfonate) is a cation-exchange resin used to treat patients with hyperkalemia. Concomitant administration of kayexalate and sorbitol may induce gastrointestinal injury, which is potentially lethal. However, this well-documented complication is often underrecognized both clinically and pathologically. We propose a typical case along with colonoscopic photos and microscopic pictures. Additionally, we also present a review of the literature on this rare drug-induced side effect.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sorbitol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-Sorbitol, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-Sorbitol, FCC, FG
Sigma-Aldrich
D-Sorbitol, 99% (GC)
Sigma-Aldrich
Sorbitol F solution, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D-Sorbitol, ≥98% (GC)
Sigma-Aldrich
D-Sorbitol, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
D-Sorbitol, ≥98% (GC), BioXtra
Sigma-Aldrich
D-Sorbitol, ≥98% (GC), for molecular biology
USP
Sorbitol, United States Pharmacopeia (USP) Reference Standard
Sorbitol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
D-Sorbitol, liquid, tested according to Ph. Eur.